menu ☰
menu ˟

Lotus Edge becomes third TAVR system approved by FDA

23 Apr 2019
Boston Scientific announced its mechanically expandable transcatheter aortic valve replacement system has been approved by the FDA for treatment of patients with severe aortic stenosis.The device (Lotus Edge) is the third TAVR system approved in the ...

Click here to view the full article which appeared in Cardiology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.